@article{3fbdaaf021584279994217585eb83be5,
title = "Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas",
keywords = "ovarian cancer, BRCA1, BRCA2, cancer predisposition, BRCA testing, personalized medicine, PARP-inhibitor, single molecule molecular inversion probes, MOLECULAR INVERSION PROBES, RANDOMIZED PHASE-2 TRIAL, POLY(ADP-RIBOSE) POLYMERASE, SOMATIC MUTATIONS, PREDICTS SENSITIVITY, CANCER INCIDENCE, RISK-ASSESSMENT, BREAST, GERMLINE, OLAPARIB",
author = "Weren, {Robbert D. A.} and Mensenkamp, {Arjen R.} and Michiel Simons and Astrid Eijkelenboom and Sie, {Aisha S.} and Hicham Ouchene and {van Asseldonk}, Monique and Gomez-Garcia, {Encarna B.} and Blok, {Marinus J.} and {de Hullu}, {Joanne A.} and Nelen, {Marcel R.} and Alexander Hoischen and Johan Bulten and Tops, {Bastiaan B. J.} and Nicoline Hoogerbrugge and Ligtenberg, {Marjolijn J. L.}",
year = "2017",
month = feb,
doi = "10.1002/humu.23137",
language = "English",
volume = "38",
pages = "226--235",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley",
number = "2",
}